About Us
Reinventing Remote Robotic Surgery to
Make Life-Saving Interventions Accessible to All.
Critical endovascular conditions such as cardiac arrests and strokes require rapid
intervention. But millions don’t get treatment in time.
To bridge this gap, we are developing endovascular robotic solutions that can be deployed remotely to expand treatment access and deliver superior patient outcomes.
A medtech spin-off from
ETH Zurich
Founded in 2021, Nanoflex Robotics was spun out of a leading research university in
Switzerland, ETH Zurich. Today, we are a medical device company specializing in the development of
telerobotic solutions to treat a range of critical endovascular diseases. We are driven by our mission to
widen access to lifesaving treatments and seek like-minded partners, hospitals and physicians to join us
on our journey.
Contact Us
Our Team
